Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Celsius Holdings, Inc. (CELH) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

Celsius Holdings, Inc.Trade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

Celsius Holdings, Inc. vs Intuitive Surgical, Inc. — how do they compare? Celsius Holdings, Inc. trades at $27.27 (market cap $7.11B), while Intuitive Surgical, Inc. trades at $398.34 (market cap $141.75B). The key difference: Intuitive Surgical, Inc. is far larger — about 19.9× Celsius Holdings, Inc.'s market cap, and Intuitive Surgical, Inc. is trading nearer its 52-week high, Celsius Holdings, Inc. nearer its low. Which is the better fit depends on your goals.

CELHISRG
Market Cap
$7.11B$141.75B
Sector
Consumer StaplesHealth
52-Week High
$64.86$592.85
52-Week Low
$23.77$332.02
Enterprise Value
$8.90B$136.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Celsius Holdings, Inc.

CELH trades at $27.21, down 2.02% on the day, with technical indicators signaling a bearish trend. The company reported Q2 2026 earnings of $0.36 per share, missing estimates of $0.4139, while revenue grew 11% year-over-year. Recent news highlights leadership changes and an ongoing shareholder investigation. The stock faces pressure from slowing core-brand growth but benefits from strong analyst support and a partnership with PepsiCo.

Outlook: High growth potential via international expansion and PepsiCo distribution, but execution risks and margin pressures persist. Risks include competitive threats and delayed growth projections. Analyst consensus is strongly bullish with a $44.08 price target, suggesting significant upside if operational challenges are overcome.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $393.38, up 3.85% on the day, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The stock exhibits premium valuation metrics, including a P/E of 46.01 and P/S of 13.08, supported by robust revenue growth, which reached $10.06B in 2025, and high net income margins of 28.45%. Recent news highlights analyst upgrades and optimism around the da Vinci 5 system's adoption.

The outlook remains positive given durable demand and innovation, but risks include heightened competition and valuation sensitivity. Wall Street consensus is bullish with a $518.10 price target, implying significant upside, though investors should weigh premium multiples against growth sustainability and competitive pressures in the medtech space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Celsius Holdings, Inc.

Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.

Read more on CELH

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG